Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Abbott FreeStyle Libre 2 glucose monitor

Abbott warns that device batteries may overheat or catch fire

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them. 

Thumbnail

American College of Radiology ‘deeply concerned’ by ruling striking down key ACA provision

Others such as the AMA and the American Lung Association similarly blasted the decision, which could jeopardize coverage for preventative care.

Thumbnail

Deductibles discourage patients from receiving recommended imaging, new survey charges

Such behaviors may lead to delays in cancer diagnosis and treatment and adverse outcomes, experts wrote Tuesday in Radiology

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

Too much too soon? Elon Musk, other tech leaders pause AI development to review ethics

Healthcare is one of the biggest areas of opportunity for AI, with more than 500 health AI algorithms cleared by the FDA over the last several years.

Point of Care Ultrasound POCUS Lungs

Specialized lung AI tool cleared for U.S. sales

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

Thumbnail

Illumina ordered to divest Grail

The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.

dollar money graph increase finance

CMS finalizes 2024 MA payment rule with rate bump

According to CMS, MA plans will see an average payment increase of 3.32% from 2023 to 2024, worth approximately $13.8 billion in increases for next year.

Thumbnail

FDA announces third recall of 2023 for troubled heart devices

This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far.